glp-1 before pregnancy Use of drugs early in should not cause alarm, analysis suggests Study finds no major early

Once the new dose stabilizes and side effects subside, return to abdominal injection

The trial, published in the New England Journal of Medicine , involved 1,878 participants with type 2 diabetes

This continuity ensures your provider understands your medical history and can make appropriate adjustments to your treatment plan over time

CagriSema (cagrilintide/semaglutide) Pending Approval - A combination injectable medication in development, combining cagrilintide and semaglutide to enhance weight loss through appetite suppression

What else you should know You may have to stay on Zepbound for life for weight management